Literature DB >> 15539640

Expression of deoxynucleotide carrier is not associated with the mitochondrial DNA depletion caused by anti-HIV dideoxynucleoside analogs and mitochondrial dNTP uptake.

Wing Lam1, ChinShing Chen, Shuolun Ruan, Chung-Hang Leung, Yung-Chi Cheng.   

Abstract

Our previous studies suggested that the dNTP/dNDP transporter systems that exist in mitochondria for transporting dNTP/dNDP from the cytoplasm to the mitochondria for mitochondrial DNA (mtDNA) synthesis play a critical role in delayed cytotoxicity of anti-human immunodeficiency virus (HIV) dideoxynucleoside analogs in mitochondria. A protein, termed mitochondrial deoxynucleotide carrier (DNC), based on its ability to transport dNTPs in reconstituted proteoliposomes, was recently isolated. Lacking cellular information to substantiate DNC's involvement in the delayed cytotoxicity of dideoxynucleoside analogs, we expressed DNC and reconstituted it into proteoliposomes. The K(m) values for dNTPs uptake by reconstituted DNC were in the millimolar range, which is a thousandfold higher than that of the physiological level. Furthermore, we found that overexpressing DNC (wt and G177A-mutated DNC) in RKO cells did not sensitize the cells to the mtDNA depletion caused by beta-d-2',3'-dideoxycytidine (ddC), 2',3'-didehydro-2',3'-dideoxythymidine, and 2',3'-dideoxyinosine or affect the mtDNA recovery rate after ddC treatment. Mitochondria isolated from DNC-overexpressing cells did not significantly differ from that isolated from RKO cells in terms of the rate of uptake or the incorporation of dTTP into mitochondria DNA. Down-regulation of DNC expression by small interfering RNA was also ineffective in changing the action of dideoxynucleoside analogs on the mtDNA depletion and the rate of dTTP uptake into isolated mitochondria. Down-regulation of both DNC and thymidine kinase-2 also did not cause mtDNA depletion. We conclude that DNC does not play an important role in the delayed cytotoxicity (mtDNA depletion) of anti-HIV dideoxynucleoside analogs and dNTPs uptake into mitochondria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539640     DOI: 10.1124/mol.104.007120

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

Review 1.  The role of transporters in the toxicity of nucleoside and nucleotide analogs.

Authors:  Christopher A Koczor; Rebecca A Torres; William Lewis
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-04-18       Impact factor: 4.481

Review 2.  Physiological and pathological roles of mitochondrial SLC25 carriers.

Authors:  Manuel Gutiérrez-Aguilar; Christopher P Baines
Journal:  Biochem J       Date:  2013-09-15       Impact factor: 3.857

3.  Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML.

Authors:  Sanduni U Liyanage; Rose Hurren; Veronique Voisin; Gaëlle Bridon; Xiaoming Wang; ChangJiang Xu; Neil MacLean; Thirushi P Siriwardena; Marcela Gronda; Dana Yehudai; Shrivani Sriskanthadevan; Daina Avizonis; Aisha Shamas-Din; Mark D Minden; Gary D Bader; Rebecca Laposa; Aaron D Schimmer
Journal:  Blood       Date:  2017-03-10       Impact factor: 22.113

4.  Knockout of Slc25a19 causes mitochondrial thiamine pyrophosphate depletion, embryonic lethality, CNS malformations, and anemia.

Authors:  Marjorie J Lindhurst; Giuseppe Fiermonte; Shiwei Song; Eduard Struys; Francesco De Leonardis; Pamela L Schwartzberg; Amy Chen; Alessandra Castegna; Nanda Verhoeven; Christopher K Mathews; Ferdinando Palmieri; Leslie G Biesecker
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-11       Impact factor: 11.205

5.  A computational model of mitochondrial AZT metabolism.

Authors:  Patrick C Bradshaw; Jiaxin Li; David C Samuels
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

6.  TREX1 acts in degrading damaged DNA from drug-treated tumor cells.

Authors:  Chuan-Jen Wang; Wing Lam; Scott Bussom; Hua-Mei Chang; Yung-Chi Cheng
Journal:  DNA Repair (Amst)       Date:  2009-07-18

7.  Behavior of thymidylate kinase toward monophosphate metabolites and its role in the metabolism of 1-(2'-deoxy-2'-fluoro-beta-L-arabinofuranosyl)-5-methyluracil (Clevudine) and 2',3'-didehydro-2',3'-dideoxythymidine in cells.

Authors:  Rong Hu; Ling Li; Bart Degrève; Ginger E Dutschman; Wing Lam; Yung-Chi Cheng
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.938

8.  Enzyme kinetics of the mitochondrial deoxyribonucleoside salvage pathway are not sufficient to support rapid mtDNA replication.

Authors:  Vishal V Gandhi; David C Samuels
Journal:  PLoS Comput Biol       Date:  2011-08-04       Impact factor: 4.475

9.  Identification and functional analysis of novel SLC25A19 variants causing thiamine metabolism dysfunction syndrome 4.

Authors:  Yuanying Chen; Boliang Fang; Xuyun Hu; Ruolan Guo; Jun Guo; Kenan Fang; Jingwen Ni; Wei Li; Suyun Qian; Chanjuan Hao
Journal:  Orphanet J Rare Dis       Date:  2021-09-29       Impact factor: 4.123

10.  A novel class of meso-tetrakis-porphyrin derivatives exhibits potent activities against hepatitis C virus genotype 1b replicons in vitro.

Authors:  Yao Cheng; Lun K Tsou; Jianfeng Cai; Toshihiro Aya; Ginger E Dutschman; Elizabeth A Gullen; Susan P Grill; Annie Pei-Chun Chen; Brett D Lindenbach; Andrew D Hamilton; Yung-Chi Cheng
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.